sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Cancer Vaccines Market...

Europe Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country and Geography

TIPRE00015128 | Pages: 177 | Pharmaceuticals | Oct 2020 | Type: Regional | Status: Published

Market Introduction

This research report provides insights into the Europe Cancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines


Get more information on this report :



Market Overview and Dynamics

The Europe cancer vaccines market is expected to reach US$ 4,680.7 million by 2027 from US$ 1,387.2 million in 2019. The market is anticipated to grow with a CAGR of 16.8% from 2020 to 2027. Factors driving demand growth include a rise in the prevalence of cancer worldwide and steps taken by European health research organisations and major players in cancer vaccines. COVID19 has had a substantial effect on the industry due to delays in the supply chain and locking conditions. However, problems in the cancer vaccine industry, such as higher prices for cancer vaccines, impede market growth.

Key Market Segments

In terms of technology, the recombinant cancer vaccines segment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019 and also is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of end user, the pediatrics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.

Major Sources and Companies Listed

The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the Europe cancer vaccines market included in the report.

Reasons to buy the report

  • To understand the Europe cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe cancer vaccines market
  • Efficiently plan M&A and partnership deals in the Europe cancer vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Europe cancer vaccines market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

Europe Cancer vaccines Market Segmentation

By Technology

  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines

Europe Cancer Vaccines Market – By Type

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccine

Europe Cancer Vaccines Market – By Indication

  • Cervical Cancer
  • Prostate Cancer
  • Other Indications

Europe Cancer Vaccines Market– By End Use

  • Pediatrics
  • Adults

Company Profiles

  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom

1.        INTRODUCTION

            1.1.       SCOPE OF THE STUDY

            1.2.       THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

            1.3.       MARKET SEGMENTATION

                         1.3.1   Cancer Vaccines Market - By Technology

                         1.3.2   Cancer Vaccines Market - By Type

                         1.3.3   Cancer Vaccines Market - By Indication

                         1.3.4   Cancer Vaccines Market - By End User

                         1.3.5   Cancer Vaccines Market - By Country

2.        KEY TAKEAWAYS

3.        RESEARCH METHODOLOGY

4.        CANCER VACCINES MARKET LANDSCAPE

            4.1.       OVERVIEW

            4.2.       PEST ANALYSIS

                         4.2.1        Europe - Pest Analysis

            4.3.       EXPERT OPINIONS

5.        CANCER VACCINES MARKET - KEY MARKET DYNAMICS

            5.1.       KEY MARKET DRIVERS

            5.2.       KEY MARKET RESTRAINTS

            5.3.       KEY MARKET OPPORTUNITIES

            5.4.       FUTURE TRENDS

            5.5.       IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.        CANCER VACCINES MARKET - EUROPE MARKET ANALYSIS

            6.1.       CANCER VACCINES - EUROPE MARKET OVERVIEW

            6.2.       CANCER VACCINES - EUROPE MARKET AND FORECAST TO 2027

            6.3.       MARKET POSITIONING/MARKET SHARE

7.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – TECHNOLOGY

            7.1.       OVERVIEW

            7.2.       TECHNOLOGY MARKET FORECASTS AND ANALYSIS

            7.3.       DENDRITIC CELLS CANCER VACCINES

                          7.3.1.         Overview

                          7.3.2.         Dendritic Cells Cancer Vaccines Market Forecast and Analysis

            7.4.       RECOMBINANT CANCER VACCINES

                          7.4.1.         Overview

                          7.4.2.         Recombinant Cancer Vaccines Market Forecast and Analysis

            7.5.       ANTIGEN CANCER VACCINES

                          7.5.1.         Overview

                          7.5.2.         Antigen Cancer Vaccines Market Forecast and Analysis

            7.6.       WHOLE CELL CANCER VACCINES

                          7.6.1.         Overview

                          7.6.2.         Whole Cell Cancer Vaccines Market Forecast and Analysis

            7.7.       VIRAL VECTOR CANCER VACCINES

                          7.7.1.         Overview

                          7.7.2.         Viral Vector Cancer Vaccines Market Forecast and Analysis

8.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – TYPE

            8.1.       OVERVIEW

            8.2.       TYPE MARKET FORECASTS AND ANALYSIS

            8.3.       PREVENTIVE CANCER VACCINES

                          8.3.1.         Overview

                          8.3.2.         Preventive Cancer Vaccines Market Forecast and Analysis

            8.4.       THERAPEUTIC CANCER VACCINES

                          8.4.1.         Overview

                          8.4.2.         Therapeutic Cancer Vaccines Market Forecast and Analysis

9.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – INDICATION

            9.1.       OVERVIEW

            9.2.       INDICATION MARKET FORECASTS AND ANALYSIS

            9.3.       CERVICAL CANCER

                          9.3.1.         Overview

                          9.3.2.         Cervical Cancer Market Forecast and Analysis

            9.4.       PROSTATE CANCER

                          9.4.1.         Overview

                          9.4.2.         Prostate Cancer Market Forecast and Analysis

            9.5.       OTHER INDICATIONS

                          9.5.1.         Overview

                          9.5.2.         Other Indications Market Forecast and Analysis

10.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – END USER

               10.1.       OVERVIEW

               10.2.       END USER MARKET FORECASTS AND ANALYSIS

               10.3.       PEDIATRICS

                             10.3.1.         Overview

                             10.3.2.         Pediatrics Market Forecast and Analysis

               10.4.       ADULTS

                             10.4.1.         Overview

                             10.4.2.         Adults Market Forecast and Analysis

11.        CANCER VACCINES MARKET REVENUE AND FORECASTS TO 2027 – COUNTRY ANALYSIS

    1. 11.1      EUROPE CANCER VACCINES MARKET OVERVIEW
    2. 11.2      EUROPE CANCER VACCINES MARKET FORECASTS AND ANALYSIS
    3. 11.3      EUROPE Cancer Vaccines Market FORECASTS AND ANALYSIS - BY COUNTRIES

                              11.3.1     Germany Cancer Vaccines Market

    • 11.3.1.1   Germany Cancer Vaccines Market by Technology
    • 11.3.1.2   Germany Cancer Vaccines Market by Type
    • 11.3.1.3   Germany Cancer Vaccines Market by Indication
    • 11.3.1.4   Germany Cancer Vaccines Market by End User

                              11.3.2     France Cancer Vaccines Market

    • 11.3.2.1   France Cancer Vaccines Market by Technology
    • 11.3.2.2   France Cancer Vaccines Market by Type
    • 11.3.2.3   France Cancer Vaccines Market by Indication
    • 11.3.2.4   France Cancer Vaccines Market by End User

                              11.3.3     Italy Cancer Vaccines Market

    • 11.3.3.1   Italy Cancer Vaccines Market by Technology
    • 11.3.3.2   Italy Cancer Vaccines Market by Type
    • 11.3.3.3   Italy Cancer Vaccines Market by Indication
    • 11.3.3.4   Italy Cancer Vaccines Market by End User

                              11.3.4     Spain Cancer Vaccines Market

    • 11.3.4.1   Spain Cancer Vaccines Market by Technology
    • 11.3.4.2   Spain Cancer Vaccines Market by Type
    • 11.3.4.3   Spain Cancer Vaccines Market by Indication
    • 11.3.4.4   Spain Cancer Vaccines Market by End User

                              11.3.5     United Kingdom Cancer Vaccines Market

    • 11.3.5.1   United Kingdom Cancer Vaccines Market by Technology
    • 11.3.5.2   United Kingdom Cancer Vaccines Market by Type
    • 11.3.5.3   United Kingdom Cancer Vaccines Market by Indication
    • 11.3.5.4   United Kingdom Cancer Vaccines Market by End User

12.        IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANCER VACCINES MARKET

               12.1        North America

               12.2        Europe

               12.3        Asia-Pacific

               12.4        Rest of the World

13.        INDUSTRY LANDSCAPE

               13.1.       MERGERS AND ACQUISITIONS

               13.2.       AGREEMENTS, COLLABORATIONS AND JOINT VENTURES

               13.3.       NEW PRODUCT LAUNCHES

               13.4.       EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14.        CANCER VACCINES MARKET, KEY COMPANY PROFILES

               14.1.     ASTRAZENECA

                              14.1.1.      Key Facts

                              14.1.2.      Business Description

                              14.1.3.      Products and Services

                              14.1.4.      Financial Overview

                              14.1.5.      SWOT Analysis

                              14.1.6.      Key Developments

               14.2.     GLAXOSMITHKLINE PLC.

                              14.2.1.      Key Facts

                              14.2.2.      Business Description

                              14.2.3.      Products and Services

                              14.2.4.      Financial Overview

                              14.2.5.      SWOT Analysis

                              14.2.6.      Key Developments

               14.3.     ADURO BIOTECH INC

                              14.3.1.      Key Facts

                              14.3.2.      Business Description

                              14.3.3.      Products and Services

                              14.3.4.      Financial Overview

                              14.3.5.      SWOT Analysis

                              14.3.6.      Key Developments

               14.4.     PFIZER INC.

                              14.4.1.      Key Facts

                              14.4.2.      Business Description

                              14.4.3.      Products and Services

                              14.4.4.      Financial Overview

                              14.4.5.      SWOT Analysis

                              14.4.6.      Key Developments

               14.5.     SANOFI

                              14.5.1.      Key Facts

                              14.5.2.      Business Description

                              14.5.3.      Products and Services

                              14.5.4.      Financial Overview

                              14.5.5.      SWOT Analysis

                              14.5.6.      Key Developments

               14.6.     BRISTOL-MYERS SQUIBB

                              14.6.1.      Key Facts

                              14.6.2.      Business Description

                              14.6.3.      Products and Services

                              14.6.4.      Financial Overview

                              14.6.5.      SWOT Analysis

                              14.6.6.      Key Developments

               14.7.     MODERNA, INC.

                              14.7.1.      Key Facts

                              14.7.2.      Business Description

                              14.7.3.      Products and Services

                              14.7.4.      Financial Overview

                              14.7.5.      SWOT Analysis

                              14.7.6.      Key Developments

               14.8.     ONCBIOMUNE PHARMACEUTICALS INC.

                              14.8.1.      Key Facts

                              14.8.2.      Business Description

                              14.8.3.      Products and Services

                              14.8.4.      Financial Overview

                              14.8.5.      SWOT Analysis

                              14.8.6.      Key Developments

               14.9.     MAXIVAX

                              14.9.1.      Key Facts

                              14.9.2.      Business Description

                              14.9.3.      Products and Services

                              14.9.4.      Financial Overview

                              14.9.5.      SWOT Analysis

                              14.9.6.      Key Developments

               14.10.     NOUSCOM

                              14.10.1.      Key Facts

                              14.10.2.      Business Description

                              14.10.3.      Products and Services

                              14.10.4.      Financial Overview

                              14.10.5.      SWOT Analysis

                              14.10.6.      Key Developments

15.        APPENDIX

               15.1.       ABOUT THE INSIGHT PARTNERS

               15.2.       GLOSSARY OF TERMS

LIST OF TABLES

Table 1. Europe Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 4. Europe Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
Table 6. Germany Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 9. Germany Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. UK Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. UK Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 12. UK Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 13. UK Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 14. Incidence, Mortality and Prevalence by cancer site, 2018, France
Table 15. France Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 16. France Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 17. France Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 18. France Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Incidence, Mortality and Prevalence by cancer site, 2018, Spain
Table 20. Spain Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Spain Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 22. Spain Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 23. Spain Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 24. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
Table 25. Italy Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. Italy Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 27. Italy Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 29. Organic Developments Done By Companies
Table 30. Inorganic Developments Done By Companies
Table 31. Glossary of Terms, Cancer Vaccines Market

 

LIST OF FIGURES

Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Segmentation – By Region
Figure 3. Europe Cancer Vaccines Market Overview
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019
Figure 5. Cancer Vaccines Market in US to Show Remarkable Growth During Forecast Period
Figure 7. Europe PEST Analysis
Figure 8. Cancer Statistics, 2020
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 10. Europe Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)
Figure 12. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 21. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 25. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Europe: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. Europe Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 29. Europe: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
Figure 30. Germany: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)

 

 

The List of Companies - Europe Cancer Vaccines Market

  1. AstraZeneca
  2. GlaxoSmithKline plc.
  3. Aduro Biotech Inc
  4. Pfizer Inc.
  5. Sanofi
  6. Bristol-Myers Squibb
  7. Moderna, Inc.
  8. OncBioMune Pharmaceuticals Inc.
  9. MaxiVAX
  10. Nouscom

 

  • To understand the Europe cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe cancer vaccines market
  • Efficiently plan M&A and partnership deals in the Europe cancer vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Europe cancer vaccines market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1500
Site License
$4000
$2000
Enterprise License
$5000
$2500
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription